|
LEMD3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.79960515775701E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.21349999943266E-08 |
| Normal-vs-Stage2 |
1.6864999999866E-06 |
| Normal-vs-Stage3 |
4.80879780440091E-11 |
| Normal-vs-Stage4 |
1.22980514660753E-11 |
| Stage1-vs-Stage2 |
5.641200E-01 |
| Stage1-vs-Stage3 |
5.470300E-02 |
| Stage1-vs-Stage4 |
1.821620E-03 |
| Stage2-vs-Stage3 |
4.288800E-01 |
| Stage2-vs-Stage4 |
8.279900E-02 |
| Stage3-vs-Stage4 |
2.150600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.06110009667759E-10 |
| Normal-vs-AfricanAmerican |
3.558100E-04 |
| Normal-vs-Asian |
1.3488000000228E-06 |
| Caucasian-vs-AfricanAmerican |
5.413800E-01 |
| Caucasian-vs-Asian |
8.095000E-01 |
| AfricanAmerican-vs-Asian |
6.959600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.59459120854899E-12 |
| Normal-vs-Female |
2.38410002850742E-09 |
| Male-vs-Female |
1.192410E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.88379999669309E-08 |
| Normal-vs-Age(41-60Yrs) |
4.80469997121702E-09 |
| Normal-vs-Age(61-80Yrs) |
1.44809719770933E-11 |
| Normal-vs-Age(81-100Yrs) |
7.609900E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.064800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.136200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.328800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.118000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.244400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.502600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.344700E-03 |
| Classical-VS-Follicular |
2.255000E-01 |
| Classical-VS-Other |
3.135000E-01 |
| Classical-VS-Normal |
7.6725999997862E-09 |
| Tall-VS-Follicular |
5.818000E-02 |
| Tall-VS-Other |
6.097800E-01 |
| Tall-VS-Normal |
1.33959998649402E-09 |
| Follicular-VS-Other |
6.596800E-01 |
| Follicular-VS-Normal |
2.89599999980794E-07 |
| Other-VS-Normal |
2.297200E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.3080004574183E-10 |
| Normal-vs-N1 |
1.31180000195741E-09 |
| N0-vs-N1 |
2.313200E-01 |
|
|
